Price range: $520.00 through $930.00
Retatrutide is a synthetic multi-agonist peptide designed to interact with glucagon (GCGR), glucose-dependent insulinotropic polypeptide (GIPR), and glucagon-like peptide-1 (GLP-1R) receptors. Structural modifications enhance resistance to enzymatic degradation and incorporate a fatty diacid moiety to promote albumin binding, extending the compound half-life in biological research models for sustained receptor engagement.
Retatrutide is a synthetic multi-agonist peptide designed to interact with glucagon (GCGR), glucose-dependent insulinotropic polypeptide (GIPR), and glucagon-like peptide-1 (GLP-1R) receptors. Structural modifications enhance resistance to enzymatic degradation and incorporate a fatty diacid moiety to promote albumin binding, extending the compound half-life in biological research models for sustained receptor engagement.
Used in in vitro research examining multi-receptor binding kinetics across GCGR, GIPR, and GLP-1R pathways, cAMP signaling responses, comparative agonist activity versus single- and dual-receptor peptides, ligand competition assays, and receptor internalisation dynamics across incretin and glucagon systems.
TRUBLU Peptides supplies research-grade Retatrutide in wholesale kits of 10 vials, available in 15mg, 20mg, 30mg, and 40mg configurations—all offered at a single, streamlined wholesale price point. Each batch is verified at 99%+ purity through HPLC and Mass Spectrometry analysis. Reconstitute with bacteriostatic water. Store at -20°C.
WARNING: For research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research professionals only.
| Size | 15mg, 20mg, 30mg, 40mg |
|---|
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.